Blood filter shows promise for autoimmune patients
NCT ID NCT04078698
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested the safety and effectiveness of a medical device called GLOBAFFIN® in 34 adults with autoimmune diseases. The device filters harmful antibodies from the blood to help control the disease. The main goal was to measure how much antibody levels dropped after each treatment. This is not a cure, but a way to manage the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonissenkrankenhaus Flensburg
Flensburg, 24939, Germany
-
Städtisches Klinikum Braunschweig
Braunschweig, Lower Saxony, 38126, Germany
-
University of Ulm - Department of Neurology
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.